prognosis
Last reviewed 01/2018
- prognosis for people with small-cell lung cancer is poor
- without treatment, it has an aggressive clinical course with a life
expectancy of approximately 3.5 months for limited-stage disease and 6
weeks for extensive-stage disease
- with treatment
- median survival with treatment is approximately 14-18 months for
limited-stage disease and 9-12 months for extensive-stage disease
- approximately 20-40% of patients with limited-stage disease and less than 5% of patients with extensive-stage disease survive for 2 years. Survivors often continue to relapse up to, and occasionally after, 5 years
- median survival with treatment is approximately 14-18 months for
limited-stage disease and 9-12 months for extensive-stage disease
- without treatment, it has an aggressive clinical course with a life
expectancy of approximately 3.5 months for limited-stage disease and 6
weeks for extensive-stage disease
Reference: